Enzo Biochem, Inc.
ENZ
Market Cap$57.89M
Close$
$-0.92
186.9% downside
Current Fair Value
186.9% downsideOvervalued by 186.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.89 Million |
|---|---|
| Enterprise Value | $1.10 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.65 |
| Beta | 0.09 |
| Outstanding Shares | 51,225,734 |
| Avg 30 Day Volume | 100,419 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.78 |
|---|---|
| PEG | -2.44 |
| Price to Sales | - |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | 0.09 |
| Enterprise Value to EBIT | -0.24 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 3.14 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
ESG Score
No data
About Enzo Biochem, Inc.
CEO: Elazar Rabbani